Capricor Therapeutics, Inc. (FRA:4LN2)

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $11.13M USD in the twelve months ending September 30, 2025, down -52.08% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $22.27M, down -11.55%.

• Revenue (ttm): $11.13M
• Revenue Growth: -52.08%
• P/S Ratio: 111.74
• Revenue / Employee: $69.57K
• Employees: 160
• Market Cap: 1.06B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	22.27M	-2.91M	-11.55%
Dec 31, 2023	25.18M	22.63M	886.81%
Dec 31, 2022	2.55M	2.31M	941.85%
Dec 31, 2021	244.90K	-65.35K	-21.06%
Dec 31, 2020	310.25K	-694.78K	-69.13%
Dec 31, 2019	1.01M	-666.33K	-39.87%
Dec 31, 2018	1.67M	-994.98K	-37.32%
Dec 31, 2017	2.67M	-1.33M	-33.32%
Dec 31, 2016	4.00M	-1.52M	-27.53%
Dec 31, 2015	5.52M	730.95K	15.27%
Dec 31, 2014	4.79M	4.28M	851.19%
Dec 31, 2013	503.23K	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	1.35M	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-